Cargando…
Identification of synergistic drug combinations using breast cancer patient-derived xenografts
Compared with other breast cancer subtypes, triple-negative breast cancer (TNBC) is associated with relatively poor outcomes due to its metastatic propensity, frequent failure to respond to chemotherapy, and lack of alternative, targeted treatment options, despite decades of major research efforts....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992640/ https://www.ncbi.nlm.nih.gov/pubmed/32001757 http://dx.doi.org/10.1038/s41598-020-58438-0 |